ladybugmandy
Senior Member
- Messages
- 25
Referat fra Prof. De Meirleir
og Dr Petersons XMRV-foredrag
i Madrid 26.05
Rutt @ 14:50
*Yesterday we have gone to Madrid to hear Dr. Dan
Peterson's lecture.
It was an all morning session about XMRV, and the
first to talk was Dr. Dan Peterson. He shared with
everybody some of the findings in XMRV (nothing
new) with many references to Dr. Judy Mikovits and
the WPI, and his slides were the same that Dr.
Mikovits uses in her lectures. The reasons for leaving
the WPI were more a personal decision in order to
have more time for himself after 25 years of service
in WPI. He seems to be having a nice rest and is
very happy to have the time to go sailing again.
At some point It was mentioned by Daniel Peterson,
that so far the best biomarker for CFS is the Low
NKCell function test, and that if your budget was
restricted, this would be the test to do, I guess He
was referring to the same direction than Dr. Klimas
is always talking about as well. http://bit.ly/cJ7YVc
The second lecture was from Dr. Kenny De Meirleir,
very interesting, focused on the fact that the most
important thing now is to have a simple and good
XMRV Test for all the researchers. He assured that
they already have the test and it works, and it is a
matter of days that they will make it available, 3 to
4 weeks probably.
De Meirleir also talked about all the work that is
being done and possible treatments, but curiously
never mentioned the Ampligen. Dr. Marc Fremont's
lecture was very technical about this test, and
finally, Dr. Chris Roelant talked about the urine test
they already have, which indicates intestinal
dysbiosis is present in these patients.
Some of the questions posted in the Conference
were regarding the recent German study, and the
fact that XMRV is 3 times more present in immune
compromised patients already tells you that there is
an immune problem on CFS patients where most of
them have the retrovirus.
There are three pathways affected on CFS which
affect muscles and CNS:
25-A
PKR
NO
There are also 3 pats of the immune system
affected:
Th1 Linked to viral reactivation and intracellular
infection due to an excessive hypersensitivity
Th2 Linked to pathogens, allergies and inflammation
and blood brain barrier dysfunction
Th17 Linked to autoimmunity and inflammation and
blood brain barrier dysfunction
De Meirleir elaborated later on that Th2 imbalance
that causes diseases such as CFS, Autism, HIV, MCS,
Mercury exposure, Allergies, Parasites.
Th1 relates to cell-based immunity Th2 relates to
Humoral immunity
You can see a bit on the conference in this link:
http://www.youtube.com/watch?v=ywLnptBQLeg
When we asked Daniel Peterson to comment on Dr.
Hubert lecture of last Monday in London, his answer
was that Huber had positives 17 of the 19 samples
that were sent to her, but She only spoke of the
samples of other doctors who have tested negative.
Daniel Peterson has said that once again we face the
uncertainty of correctness in the samples tested, but
also added that if She would have done a good job,
She could not have all negatives, at least 3% would
be positive, as we see is happening with the recent
German study.
When we asked about the fact that HIV patients that
are XMRV positive and have CFS, are not reacting to
their current antiretroviral treatment, and that could
lead to the possibility that XMRV is just a passenger
virus in a depressed immune system, his answer was
that actually that would be one possibility, and the
other one is that they are taking the wrong drug,
because XMRV is a different retrovirus, and they are
being treated for HIV.
When we asked about the German study, and the
fact that XMRV has been found now in the respiratory
tract, and that could lead to new ways to detect
XMRV different from the ones used in WPI, He said
that is a big possibility. As we know blood is not the
reservoir of XMRV, maybe the brain or the liver
There were some other questions regarding the
prevalence of CFS in children, banning blood
donations, etc
I will try to add the whole Conference next week if I
have the time to do so, but basically these would be
the headlines of the Conference.*
og Dr Petersons XMRV-foredrag
i Madrid 26.05
Rutt @ 14:50
*Yesterday we have gone to Madrid to hear Dr. Dan
Peterson's lecture.
It was an all morning session about XMRV, and the
first to talk was Dr. Dan Peterson. He shared with
everybody some of the findings in XMRV (nothing
new) with many references to Dr. Judy Mikovits and
the WPI, and his slides were the same that Dr.
Mikovits uses in her lectures. The reasons for leaving
the WPI were more a personal decision in order to
have more time for himself after 25 years of service
in WPI. He seems to be having a nice rest and is
very happy to have the time to go sailing again.
At some point It was mentioned by Daniel Peterson,
that so far the best biomarker for CFS is the Low
NKCell function test, and that if your budget was
restricted, this would be the test to do, I guess He
was referring to the same direction than Dr. Klimas
is always talking about as well. http://bit.ly/cJ7YVc
The second lecture was from Dr. Kenny De Meirleir,
very interesting, focused on the fact that the most
important thing now is to have a simple and good
XMRV Test for all the researchers. He assured that
they already have the test and it works, and it is a
matter of days that they will make it available, 3 to
4 weeks probably.
De Meirleir also talked about all the work that is
being done and possible treatments, but curiously
never mentioned the Ampligen. Dr. Marc Fremont's
lecture was very technical about this test, and
finally, Dr. Chris Roelant talked about the urine test
they already have, which indicates intestinal
dysbiosis is present in these patients.
Some of the questions posted in the Conference
were regarding the recent German study, and the
fact that XMRV is 3 times more present in immune
compromised patients already tells you that there is
an immune problem on CFS patients where most of
them have the retrovirus.
There are three pathways affected on CFS which
affect muscles and CNS:
25-A
PKR
NO
There are also 3 pats of the immune system
affected:
Th1 Linked to viral reactivation and intracellular
infection due to an excessive hypersensitivity
Th2 Linked to pathogens, allergies and inflammation
and blood brain barrier dysfunction
Th17 Linked to autoimmunity and inflammation and
blood brain barrier dysfunction
De Meirleir elaborated later on that Th2 imbalance
that causes diseases such as CFS, Autism, HIV, MCS,
Mercury exposure, Allergies, Parasites.
Th1 relates to cell-based immunity Th2 relates to
Humoral immunity
You can see a bit on the conference in this link:
http://www.youtube.com/watch?v=ywLnptBQLeg
When we asked Daniel Peterson to comment on Dr.
Hubert lecture of last Monday in London, his answer
was that Huber had positives 17 of the 19 samples
that were sent to her, but She only spoke of the
samples of other doctors who have tested negative.
Daniel Peterson has said that once again we face the
uncertainty of correctness in the samples tested, but
also added that if She would have done a good job,
She could not have all negatives, at least 3% would
be positive, as we see is happening with the recent
German study.
When we asked about the fact that HIV patients that
are XMRV positive and have CFS, are not reacting to
their current antiretroviral treatment, and that could
lead to the possibility that XMRV is just a passenger
virus in a depressed immune system, his answer was
that actually that would be one possibility, and the
other one is that they are taking the wrong drug,
because XMRV is a different retrovirus, and they are
being treated for HIV.
When we asked about the German study, and the
fact that XMRV has been found now in the respiratory
tract, and that could lead to new ways to detect
XMRV different from the ones used in WPI, He said
that is a big possibility. As we know blood is not the
reservoir of XMRV, maybe the brain or the liver
There were some other questions regarding the
prevalence of CFS in children, banning blood
donations, etc
I will try to add the whole Conference next week if I
have the time to do so, but basically these would be
the headlines of the Conference.*
